Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Abbott Laboratories (ABT)
NYSE:ABT
ABT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$99.71 - $132.65
Previous CloseN/A
Volume1.03M
Average Volume (3M)6.80M
Market Cap
$225.79B
Enterprise Value$206.67B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)17.0
Beta0.52
Next Earnings
Apr 16, 2025EPS Estimate
1.07Last Dividend Ex-Date
Jan 15, 2025Dividend Yield1.72%
Share Statistics
EPS (TTM)7.66
Shares Outstanding1,734,455,200
10 Day Avg. Volume5,393,698
30 Day Avg. Volume6,803,751
Standard Deviation0.06
R-Squared0.38
Alpha0.00096
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)5.48
Price to Cash Flow (P/CF)20.90
P/FCF Ratio26.30
Enterprise Value/Market Cap0.92
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit9.34
Enterprise Value/Ebitda19.22
Forecast
1Y Price Target
$137.43Price Target Upside4.01% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering15
---
Bulls Say, Bears Say
Bulls Say
Acquisition StrategyThere is a potential for ABT to use its balance sheet for small to midsized acquisitions, which could significantly drive upside.
EarningsMedical Devices was a standout performer, delivering 14.0% organic growth and sales of $5.05B vs the Street's $4.97B expectation.
Growth OutlookABT projects organic sales growth of 7.5-8.5% for 2025, which is higher than the Street's forecast of ~7%, reflecting strong future growth expectations.
Bears Say
Diagnostic Segment ChallengesDiagnostics segment missed expectations largely due to lower COVID test sales.
Legal IssuesOngoing NEC litigation where the MDL is set to commence remains a key debate.
Revenue MissRevenue miss attributed to greater FX headwinds and lower-than-expected COVID testing revenue.
---
Ownership Overview
0.47% Insiders
24.50% Mutual Funds
21.61% Other Institutional Investors
33.85% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ABT FAQ
What was Abbott Laboratories’s price range in the past 12 months?
Abbott Laboratories lowest stock price was $99.71 and its highest was $132.65 in the past 12 months.
What is Abbott Laboratories’s market cap?
Abbott Laboratories’s market cap is $225.79B.
When is Abbott Laboratories’s upcoming earnings report date?
Abbott Laboratories’s upcoming earnings report date is Apr 16, 2025 which is in 55 days.
How were Abbott Laboratories’s earnings last quarter?
Abbott Laboratories released its earnings results on Jan 22, 2025. The company reported $1.34 earnings per share for the quarter, beating the consensus estimate of $1.336 by $0.004.
Is Abbott Laboratories overvalued?
According to Wall Street analysts Abbott Laboratories’s price is currently Undervalued.
Does Abbott Laboratories pay dividends?
Abbott Laboratories pays a Quarterly dividend of $0.589 which represents an annual dividend yield of 1.72%. See more information on Abbott Laboratories dividends here
What is Abbott Laboratories’s EPS estimate?
Abbott Laboratories’s EPS estimate is 1.07.
How many shares outstanding does Abbott Laboratories have?
Abbott Laboratories has 1,734,455,200 shares outstanding.
What happened to Abbott Laboratories’s price movement after its last earnings report?
Abbott Laboratories reported an EPS of $1.34 in its last earnings report, beating expectations of $1.336. Following the earnings report the stock price went up 0.848%.
Which hedge fund is a major shareholder of Abbott Laboratories?
Currently, no hedge funds are holding shares in ABT
---
Abbott Labs Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$137.43 (4.01% Upside)
$137.43 (4.01% Upside)
Blogger Sentiment
Bullish
ABT Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 643.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $65.2M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 0.6%
Last 30 Days ▼ 0.5%
Last 30 Days ▼ 0.5%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
18.25%
12-Months-Change
Fundamentals
Return on Equity
14.49%
Trailing 12-Months
Asset Growth
3.14%
Trailing 12-Months
Company Description
Abbott Laboratories
Abbott Laboratories offers a diversified line of healthcare products. It operates through four reportable segments: Established Pharmaceutical Products International (includes international sales of branded generic pharmaceutical products), Nutritional Products Diagnostic Products and Medical Devices. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
---
ABT Company Deck
---
ABT Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong growth across several segments, particularly in medical devices and adult nutrition, alongside effective financial management and strategic guidance for 2025. However, challenges such as foreign exchange impacts, market dynamics in China, and an increased tax rate were noted.Read More>---
ABT Net sales Breakdown
42.10% Medical Devices
24.90% Diagnostic Products
20.33% Nutritional Products
12.63% Established Pharmaceutical Products
0.03% Other
---
ABT Stock 12 Month Forecast
Average Price Target
$137.43
▲(4.01% Upside)
Technical Analysis
Best Analysts Covering ABT
1 Year
1 Year Success Rate
25/26 ratings generated profit
1 Year Average Return
+20.67%
assigned a buy rating 29 days ago
Copying Rick Wise's trades and holding each position for 1 Year would result in 96.15% of your transactions generating a profit, with an average return of +20.67% per trade.
---